A detailed history of Gamma Investing LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 39,453 shares of ABBV stock, worth $6.68 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
39,453
Previous 36,014 9.55%
Holding current value
$6.68 Million
Previous $7.11 Billion 1.42%
% of portfolio
0.6%
Previous 0.71%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

BUY
$164.99 - $203.87 $567,400 - $701,108
3,439 Added 9.55%
39,453 $7.01 Billion
Q3 2024

Oct 04, 2024

BUY
$163.84 - $199.33 $1.31 Million - $1.6 Million
8,014 Added 28.62%
36,014 $7.11 Billion
Q2 2024

Jul 02, 2024

BUY
$154.79 - $180.76 $1.34 Million - $1.56 Million
8,640 Added 44.63%
28,000 $4.8 Billion
Q1 2024

Apr 05, 2024

BUY
$159.82 - $182.1 $492,725 - $561,414
3,083 Added 18.94%
19,360 $3.53 Billion
Q4 2023

Feb 01, 2024

BUY
$137.6 - $154.97 $2.24 Million - $2.52 Million
16,277 New
16,277 $2.68 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $299B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.